Vertex Pharmaceuticals Stock Rises 1.27% to $441.20: What Investors Should Know On the latest trading day, shares of Vertex Pharmaceuticals (VRTX) closed at $441.20, marking a gain of 1.27% from …
Tag:
stock market
-
-
Mastering the Markets: A Guide to IMC Prosperity 4 For university students aiming to break into the high-stakes world of quantitative finance, few opportunities provide as much hands-on experience as …
-
Betashares Refines RBTZ ETF: A Strategic Shift Toward Humanoid Robotics and Physical AI Betashares has announced a significant overhaul of its Global Robotics and Artificial Intelligence ETF (RBTZ), marking a …
-
Royal Caribbean Expansion Continues Despite Market Volatility Royal Caribbean is continuing its strategic expansion, particularly at the crucial PortMiami, with the construction of “Terminal G,” slated for completion in 2027. …
-
Caesars Entertainment Expands Online Casino Offerings with Aristocrat Slots in West Virginia Caesars Entertainment, Inc. Has become the first online casino operator in West Virginia to launch a suite of …
-
Palm Oil Market Update: Prices Rise Amidst Global Economic Factors The palm oil market is experiencing increased volatility, with prices rising nearly 2% due to a confluence of factors including …
-
Solana Foundation Launches Developer Platform, Attracting Industry Giants The Solana Foundation has officially launched the Solana Developer Platform (SDP), a new infrastructure designed to simplify blockchain integration for traditional financial …
-
US Economy Faces Inflationary Risks Amidst Iran War and Policy Challenges WASHINGTON, DC – The US economy is increasingly vulnerable to inflationary pressures stemming from a confluence of factors, including …
-
Seafarms Group Revives Project Sea Dragon with AUD 750,000 Asset Acquisition SYDNEY – Australian aquaculture firm Seafarms Group Ltd (ASX: SFG) has acquired the assets of Project Sea Dragon Pty …
-
MetaVia Advances Obesity Drug DA-1726 into Higher-Dose Phase 1 Trials Cambridge, Mass. – MetaVia Inc. (Nasdaq: MTVA) announced on March 18, 2026, that the Institutional Review Board (IRB) at Clinical …
Newer Posts